---
$id: https://graph.org.ai/products/commodity/51201802
$type: Product
source: UNSPSC
code: "51201802"
title: "Filgrastim"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Filgrastim

**UNSPSC Code**: 51201802
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic colony stimulating factor with the molecular formula C845H1339N223O243S9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PVI5M0M1GW, more generally known as filgrastim. European Medicines Agency schedules filgrastim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07627MIG. The term FILGRASTIM is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 5, no. 3 1991, list 31. FILGRASTIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule filgrastim under HS 30012090 and SITC 54162. As of Q4 2014, FILGRASTIM remains the US FDA Preferred Term for this commodity. Filgrastim bears US NLM identifiers UMLS ID C0210630 and NCI Concept Code C1474. SMILES: NONE.

